Seattle Genetics

Seattle Genetics plans public stock offering
Yahoo/AP
Wed, 02/2/11 - 09:01 am
stock offering
Seattle Genetics
Smart Money's 9 Top Biotech Stock Picks
Seeking Alpha
Mon, 01/17/11 - 12:53 pm
biotech
Cadence Pharmaceuticals
Cell Therapeutics
Enzon
Geron
Exelixis
Seattle Genetics
Savient
Vivus
Theravance
Biotech Stock Mailbag: Best Stocks to Watch in '11
TheStreet.com
Fri, 01/7/11 - 07:21 am
Oncothyreon
Xoma
Amarin
Opexa
Human Genome
Seattle Genetics
Vertex Pharmaceuticals
Merck
Dendreon
Biogen Idec
Amgen
Pharmasset
Seattle Genetics in $8M deal with Pfizer
Bizjournals.com
Thu, 01/6/11 - 12:16 pm
Pfizer
Seattle Genetics
ADC products
Seattle Genetics Looks Attractive on Fundamentals, Pipeline
Seeking Alpha
Thu, 12/30/10 - 11:07 am
Seattle Genetics
cancer
monoclonal antibodies
The Winner of ASH 2010: Seattle Genetics
Seeking Alpha
Mon, 12/20/10 - 09:59 am
ASH
Seattle Genetics
Celgene
GSK
Immunogen
Micromet
Novartis
Pfizer
YM BioSciences
Sanofi
Biotech Calendar: FDA Drug Approvals in 2011
TheStreet.com
Mon, 12/13/10 - 12:26 pm
MannKind
Afrezza
Alimera
pSivida
Seattle Genetics
brentuximab vedotin
Illuvien
AstraZeneca
Zictifa
Clinical Data
Vilazodone
Orexigen
Contrave
Bristol-Myers Squibb
Yervoy
Pfizer
Protalix BioTherapeutics
UPLYSO
Xiafaxan
Salix
Human Genome Sciences
Benlysta
Dendreon
Provenge
InterMune
Esbriet
Cell Therapeutics
pixantrone
Forest Labs
Daxas
MELA Sciences
MelaFind
XenoPort
GSK
Horizant
Spectrum Pharmaceuticals
Fusilev
Adventrx
Vertex Pharmaceuticals
Telaprevir
Winners and Losers at the Hematology Society Meeting
Motley Fool
Wed, 12/8/10 - 06:54 pm
ONYX Pharmaceuticals
Seattle Genetics
Pfizer
Celgene
Immunogen
Novartis
Bristol-Myers Squibb
Takeda
JNJ
Seattle Genetics `Guided Missile' Drug Blasts Rare Lymphoma in New Study
Bloomberg
Tue, 12/7/10 - 12:07 pm
Seattle Genetics
lymphoma
Takeda
Seattle Genetics and Millennium Report Positive Data from Pivotal Trial of Brentuximab Vedotin (SGN-35) in Relapsed or Refractory Hodgkin Lymphoma at ASH Annual Meeting
Yahoo/BusinessWire
Sun, 12/5/10 - 11:47 am
Seattle Genetics
Millennium
brentuximab vedotin
SGN-35
Hodgkin's lymphoma
Takeda
U.S. Pharma: Latest Analyst Actions
Seeking Alpha
Sun, 12/5/10 - 11:35 am
Seattle Genetics
Incyte
Biodel
Cadence Pharmaceuticals
NeurogesX
Metabolix
Gilead Sciences
Pfizer
Is Seattle Genetics the Next Big Thing?
Minyanville
Thu, 12/2/10 - 04:47 pm
Seattle Genetics
brentuximab vedotin
lymphoma
Biotech Calendar: Key Dates for December
TheStreet.com
Tue, 11/30/10 - 09:20 am
Delcath
Arena Pharmaceuticals
RXi Pharmaceuticals
Cell Therapeutics
Amgen
Incyte
Celgene
Corcept Therapeutics
Affymax
Targacept
Exelixis
Orexigen
ONYX Pharmaceuticals
Seattle Genetics
MannKind
Alimera
AstraZeneca
Human Genome Sciences
Lessons From A Losing Biotech Portfolio
TheStreet.com
Mon, 11/29/10 - 11:38 am
biotech
Keryx
Ariad Pharmaceuticals
Allos
Vertex Pharmaceuticals
Seattle Genetics
Human Genome Sciences
Spectrum Pharmaceuticals
Geron
StemCells
Are These Biotechs Creating Value?
Motley Fool
Mon, 11/15/10 - 11:18 am
Seattle Genetics
Human Genome Sciences
Gilead Sciences
Celgene
biotech
3 Clear Winners of ESMO 2010
Seeking Alpha
Mon, 10/25/10 - 10:35 am
ESMO
cancer
Aveo Pharmaceutical
Arqule
Dendreon
Immunogen
Roche
Medarex
Seattle Genetics
Sanofi
4 M&A Targets With Notable Open Interest
Seeking Alpha
Sun, 10/24/10 - 01:35 pm
Genzyme
Savient
Seattle Genetics
Now That's What I Call a Drug That Works (Seattle Genetics)
Motley Fool
Tue, 09/28/10 - 07:45 am
Seattle Genetics
brentuximab vedotin
Hodgkin's lymphoma
Seattle Genetics, Takeda Drug Shrinks Lymphoma Patients' Tumors in Study
Bloomberg
Mon, 09/27/10 - 10:47 am
Seattle Genetics
Takeda
lymphoma
Hodgkin's lymphoma
Seattle Genetics' Cancer Drug Fails
TheStreet.com
Mon, 09/13/10 - 12:22 pm
Seattle Genetics
leukemia
lintuzumab

Pages